Interactions on record — worth a quick check against your medications. Based on 2 of 4 ingredients. Check your meds →
Dietary supplement

Inovir Ingredients & Drug Interactions

by HoltraCeuticals

Capsule Category: Non-nutrient/non-botanical
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Inovir is a dietary supplement by HoltraCeuticals with 4 active ingredients. Its ingredients are commonly taken for heart health, prostate health, antioxidant support.Based on those ingredients, 131 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Lycopene, Inosine Monophosphate. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Inovir by HoltraCeuticals

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 4 of its 4 active ingredients.
  • No proprietary blends here — you can verify the dose of every single component.

Inovir contains four active ingredients. Lycopene is a red plant pigment with antioxidant properties.

Inosine monophosphate is a nucleotide compound that plays a role in cellular energy and metabolism. The product also includes NN dimethylglycine and pyridoxine alpha ketoglutarate, which support various metabolic processes.

The capsule also contains inactive ingredients—magnesium silicate powder, magnesium stearate, gelatin, and silicon dioxide—which help form and stabilize the supplement.

Does it work?

Couldn't assess
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not assessable

We hold no graded evidence for this product's ingredients for its stated purpose.

Why this rating?
  • The label markets this product for: antiviral and immune modulation support.
  • We looked for evidence on: viral infection, immune function, infection prevention.
  • Our graded evidence for these ingredients doesn't cover that particular purpose.

The evidence for this product's ingredients is mixed and mostly limited. Lycopene is possibly effective for prostate cancer, but the data is insufficient or shows it's not effective for bladder cancer, diabetes, high cholesterol, ALS, and exercise-induced asthma.

Inosine monophosphate lacks reliable evidence for the conditions it's been studied in—ALS, athletic performance, cancer, diabetic nerve pain, and multiple sclerosis. We have no effectiveness data on file for NN dimethylglycine or pyridoxine alpha ketoglutarate.

The evidence, ingredient by ingredient Lycopene Inosine

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 2 of 2.
  • General safety write-ups exist for 2 of 2.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Lycopene from food is generally well tolerated, and supplement doses are likewise generally well tolerated. Possible side effects from lycopene supplements include diarrhea, gas, abdominal bloating, nausea, vomiting, indigestion, and loss of appetite.

One case of chest pain was reported with a specific lycopene product, though the link to lycopene itself wasn't confirmed. Inosine commonly raises uric acid levels, which is especially risky if you have gout or kidney problems—it can cause kidney stones, uric acid crystals in urine, and, rarely, high blood pressure or kidney damage.

The safety data on NN dimethylglycine and pyridoxine alpha ketoglutarate isn't on file. For pregnancy and breastfeeding, see the FAQs below.

Side effects, ingredient by ingredient Lycopene Inosine

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 2 of the 2 matched ingredients can interact with medications — Lycopene, Inosine.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: anticoagulant / antiplatelet drugs.
  • For scale: 131 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking Inovir, double-check with your doctor or pharmacist if you take antigout drugs like allopurinol or febuxostat—inosine may reduce how well they work. Also flag any blood thinners (like warfarin) or antiplatelet drugs (like aspirin or clopidogrel) you're on, as lycopene may increase bleeding risk.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with no assessable stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

Inovir may be considered by someone looking to support prostate health through lycopene, though the evidence is limited. If you take blood thinners, antiplatelet drugs, or gout medications, you need to check with your doctor or pharmacist before starting this supplement.

Anyone with a history of kidney stones or gout should also talk it over with their healthcare provider first.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 2 of 4 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Mar 25, 2013.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Inovir, straight from the product label.

Brand HoltraCeuticals
Barcode (UPC) 837654693599
Net contents 180 Capsule(s)
Market status On market
Date entered into DSLD Mar 25, 2013
DSLD ID 19485
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Inovir by HoltraCeuticals, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
3 Capsule(s)
Maximum serving Sizes:
3 Capsule(s)
Servings per container
60
UPC/BARCODE
837654693599
IngredientAmount% DV
Lycopene5 mg--
Inosine Monophosphate1300 mg--
NN Dimethylglycine300 mg--
Pyridoxine Alpha Ketoglutarate300 mg--

Other ingredients: Magnesium silicate powder, Magnesium Stearate, Gelatin Capsule, Silicon Dioxide

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Suggested/Recommended/Usage/Directions

Suggested Use: As a dietary supplement, 3 capsules twice daily or as directed by your physician.

Precautions

Keep out of reach of children.

Warning: If you are under medical supervision, seek the advice of your physician or healthcare professional prior to the use of this product.

Storage

Store in a cool, dry place protected from light.

FDA Statement of Identity

Dietary Supplement

General Statements

*Antiviral and Immune Modulator

Brand IP Statement(s)

HOLTORF MEDICAL GROUP(R) CENTERS FOR HORMONE IMBALANCE, HYPOTHYROIDISM AND FATIGUE

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

See for yourself

Inovir by HoltraCeuticals label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Inovir by HoltraCeuticals

These are the 4 active ingredients this product is made of. Select any to open its full monograph.

Serving size3 Capsule(s) Dosage formCapsule Servings per container60 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Lycopene

Interacts with
122 drugs
5 mg per serving

Lycopene is a red plant pigment and antioxidant found mainly in tomatoes and other red fruits. Eating lycopene-rich foods is linked with possible hear...

Lycopene monograph & interactions

Inosine Monophosphate

Interacts with
9 drugs
1300 mg per serving

Inosine is a nucleoside (a building block of DNA and RNA) that the body makes on its own and is also sold as a supplement, mostly marketed for athleti...

Inosine Monophosphate monograph & interactions

NN Dimethylglycine

300 mg per serving

Pyridoxine Alpha Ketoglutarate

300 mg per serving

Other (inactive) ingredients: Magnesium silicate powder, Magnesium Stearate, Gelatin Capsule, Silicon Dioxide. These complete the product’s ingredient list but are not active constituents.

Interaction report

Inovir by HoltraCeuticals Drug Interactions

Want to check YOUR meds against Inovir?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
131Drugs
131 Moderate

Ingredients driving the most interactions

Lycopene 122

Each ingredient & the kinds of drugs it affects

For each ingredient in Inovir with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Lycopene1 drug type · 122 drugs

Anticoagulant/Antiplatelet Drugs

Theoretically, taking lycopene with anticoagulant or antiplatelet drugs might increase the risk of bleeding.
In vitro research shows that lycopene has antiplatelet effects.

Likelihood Possible Evidence D

Inosine Monophosphate1 drug type · 9 drugs

Antigout Drugs

Inosine might reduce the effects of antigout medications.
Inosine increases uric acid levels in the serum and urine, potentially resulting in hyperuricemia and reducing the effects of medications used for the prevention and treatment of gout.

Likelihood Possible Evidence D
The maker

Brand information

Manufacturer and brand details for Inovir, from the product label.

HoltraCeuticals

See all HoltraCeuticals products
Name
Kent Holtorf, MD and the Holtorf Medical Group, Inc.
City
Torrance
State
CA
Phone Number
(310) 375-2705
Pharmacist Counseling Corner

Inovir by HoltraCeuticals: Common Questions

Does Inovir by HoltraCeuticals interact with any medications?
Yes. Based on its ingredients, Inovir has a known interaction with 131 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Inovir contains 4 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Can I take Inovir if I'm pregnant?
Lycopene is rated likely safe in pregnancy, but inosine is not well studied and should be avoided during pregnancy unless your doctor advises otherwise. Since the product contains both, talk with your doctor or pharmacist about whether it's right for you.
Is it safe to take Inovir while breastfeeding?
Lycopene is rated likely safe while breastfeeding, but inosine's safety during lactation is unknown and the data advises against use. Speak with your doctor or pharmacist about whether this product is appropriate for you.
What side effects might I experience from Inovir?
Lycopene may cause diarrhea, gas, bloating, nausea, vomiting, indigestion, or loss of appetite. Inosine commonly raises uric acid levels and can lead to kidney stones or uric acid crystals in urine; rare serious effects include high blood pressure or kidney problems. Stop taking it and contact your doctor if you develop severe symptoms.
Will Inovir help with prostate health?
Lycopene, one of the active ingredients, is possibly effective for prostate cancer. The other ingredients lack reliable evidence for their intended uses. Talk with your doctor about whether Inovir is right for your specific health goals.
Is this product safe if I have gout or kidney problems?
No. Inosine raises uric acid levels and can cause kidney stones and uric acid crystals—risks that are especially serious if you have a history of gout or kidney disease. Do not take this product without discussing it with your doctor or pharmacist first.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Inovir is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Inovir label
Sources

Sources & How We Checked

Inovir's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 17 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Lycopene 10 references
  1. Sharma, J. B., Kumar, A., Kumar, A., Malhotra, M., Arora, R., Prasad, S., and Batra, S. Effect of lycopene on pre-eclampsia and intra-uterine growth retardation in primigravidas. Int J Gynaecol.Obstet. 2003;81(3):257-262. PubMed
  2. Hsiao, G., Wang, Y., Tzu, N. H., Fong, T. H., Shen, M. Y., Lin, K. H., Chou, D. S., and Sheu, J. R. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation. J Lab Clin Med 2005;146(4):216-226. PubMed
  3. Clark, P. E., Hall, M. C., Borden, L. S., Jr., Miller, A. A., Hu, J. J., Lee, W. R., Stindt, D., D'Agostino, R., Jr., Lovato, J., Harmon, M., and Torti, F. M. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse o
  4. O'Kennedy, N., Crosbie, L., Whelan, S., Luther, V., Horgan, G., Broom, J. I., Webb, D. J., and Duttaroy, A. K. Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am.J.Clin.Nutr. 2006;84(3):561-569. PubMed
  5. Jatoi, A., Burch, P., Hillman, D., Vanyo, J. M., Dakhil, S., Nikcevich, D., Rowland, K., Morton, R., Flynn, P. J., Young, C., and Tan, W. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II stu
  6. Schwenke, C., Ubrig, B., Thurmann, P., Eggersmann, C., and Roth, S. Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study. J.Urol. 2009;181(3):1098-1103. PubMed
  7. Banerjee, S., Jeyaseelan, S., and Guleria, R. Trial of lycopene to prevent pre-eclampsia in healthy primigravidas: results show some adverse effects. J.Obstet.Gynaecol.Res. 2009;35(3):477-482. PubMed
  8. Haseen, F., Cantwell, M. M., O'Sullivan, J. M., and Murray, L. J. Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. Prostate Cancer Prostatic.Dis. 2009;12(4):325-332. PubMed
  9. Ilic, D., Forbes, K. M., and Hassed, C. Lycopene for the prevention of prostate cancer. Cochrane.Database.Syst.Rev. 2011;(11):CD008007. PubMed
  10. Sawardekar SB, Patel TC, Uchil D. Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: an in vitro study. Indian J Pharmacol 2016;48:26-31. PubMed

See these in context on the Lycopene monograph →

Inosine 7 references
  1. Parkinson Study Group SURE-PD Investigators. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014;71(2):141-50.
  2. Muñoz García D, Midaglia L, Martinez Vilela J, et al. Associated inosine to interferon: results of a clinical trial in multiple sclerosis. Acta Neurol Scand. 2015;131(6):405-10. PubMed
  3. Gonsette RE, Sindic C, D'hooghe MB, et al. Boosting endogenous neuroprotection in multiple sclerosis: The association of inosine and interferon beta in relapsing-remitting Multiple Sclerosis (ASIIMS) trial. Mult Scler. 2010;16(4):455-62.
  4. Markowitz CE, Spitsin S, Zimmerman V, et al. The treatment of multiple sclerosis with inosine. J Altern Complement Med. 2009;15(6):619-25. PubMed
  5. Watanabe H, Hattori T, Kume A, et al. Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine. Medicine (Baltimore) 2020;99(35):e21576. PubMed
  6. Parkinson Study Group SURE-PD3 Investigators, Schwarzschild MA, Ascherio A, et al. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA 2021;326(10):926-939.
  7. Walk D, Nicholson K, Locatelli E, et al. Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosis. Muscle Nerve 2023;67(5):378-386. PubMed

See these in context on the Inosine monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring